REFERENCES
- Simmons D L, Botting R M, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev. 2004; 56: 387–437, [PUBMED], [INFOTRIEVE], [CSA]
- Garavito R M, Mulichak A M. The structure of mammalian cyclooxygenases. Annu Rev. Biophys Biomol Struct. 2003; 32: 183–206, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Katori M, Majima M. Cyclooxygenase-2: Its rich diversity of roles and possible application of its selective inhibitors. Inflamm Res 2000; 49: 367–392, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cui J G, Koroda H, Chandrasekharan N V, et al. Cyclooxygenase-3 gene expression in Alzheimer hippocampus and in stressed human neural cells. Neurochem Res. 2004; 29: 1731–1737, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kitamura Y, Shimohama S, Koike H, et al. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains. Biochem Biophys Res Commun 1999; 254: 582–586, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kiefer W, Dannhardt G. Novel insights and therapeutical applications in the field of inhibitors of COX-2. Curr Med Chem 2004; 11: 3147–3161, [PUBMED], [INFOTRIEVE], [CSA]
- Newton R, Kuitert L M, Bergmann M, et al. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem Biophys Res Commun. 1997; 237: 28–32, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bazan N G, Lukiw W J. Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells. J Biol Chem 2002; 277: 30359–30367, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lukiw W J, Ottlecz A, Lambrou G, et al. Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Invest Ophthalmol Vis Sci 2003; 44: 4163–4170, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sparrow J R, Boulton M. RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res. 2005; 80: 595–606, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sparrow J R, Fishkin N, Zhou J, et al. A2E, a by-product of the visual cycle. Vision Res 2003; 43: 2983–2990, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zhou J, Cai B, Jang Y P, et al. Mechanisms for the induction of HNE- MDA- and AGE-adducts, RAGE and VEGF in retinal pigment epithelial cells. Exp Eye Res. 2005; 80: 567–580, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gaillard E R, Avalle L B, Keller L M, et al. A mechanistic study of the photooxidation of A2E, a component of human retinal lipofuscin. Exp Eye Res 2004; 79: 313–319, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Castro M R, Lutz D, Edelman J L. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization. Exp Eye Res. 2004; 79: 275–285, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pogue A I, Lukiw W J. Angiogenic signaling in Alzheimer's disease. Neuroreport. 2004; 15: 1507–1510, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wang W, Bergh A, Damber J E. Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer. Clin Cancer Res. 2005; 11: 3250–3256, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Huang S P, Wu M S, Shun C T, et al. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma. J Biomed Sci 2005; 12: 229–241, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wilkinson-Berka J L. Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide. Curr Pharm Des. 2004; 10: 3331–3348, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]